Mepaco Medifood

What Mepaco Medifood does

Mepaco Medifood, legally registered as Arab Company For Pharmaceuticals and Medicinal Plants (MEPACO), is an Egypt-based pharmaceutical manufacturer headquartered in Cairo with a production facility in Enshas El Raml, Sharkeia Governorate, and an additional regional office in Alexandria. The company employs 501-1,000 people and operates under five international ISO certifications (9001:2015, 14001:2015, 45001:2018, 22000:2018, 17025:2017) covering quality, environmental, occupational health and safety, food safety, and laboratory competence. Its core technical capability is in herbal extraction, including volatile and fixed oils and in-house dry herbal extract production via a vacuum drying oven, which reduces dependence on imported raw materials.

The product portfolio spans over 100 SKUs across twelve therapeutic categories, including cardiovascular (angiotensin receptor blockers, Coenzyme Q10, L-Carnitine), antibiotics (amoxicillin-clavulanate, clindamycin, levofloxacin, nitrofurantoin), GIT products, NSAIDs and bone products, CNS medications, respiratory syrups, immune stimulants (echinacea-based), diabetic and diet control (metformin and herbal adjuncts), vitamins/minerals/antioxidants, urology, parasiticides, and a baby cereal line. The company also operates a Pharmacovigilance Department for adverse drug reaction monitoring across its marketed products.

Mepaco generates revenue through one-time sales of pharmaceutical and healthcare products distributed via pharmaceutical distribution networks, with exports to approximately 30 countries across Asia, Africa, and Europe. Pricing is not publicly disclosed; the company's stated positioning is "safe, effective and affordable medicines," with no enterprise software, subscription, or licensing model in the data. No parent company, external investors, funding rounds, M&A, or strategic partnerships are disclosed, and the company appears to be privately held.

Name

Mepaco Medifood

Legal name

Arab Company For Pharmaceuticals and Medicinal Plants

Website

https://mepaco-pharma.net

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Mepaco Medifood (Arab Company For Pharmaceuticals and Medicinal Plants) is an Egypt-based pharmaceutical manufacturer producing generic medicines, herbal remedies, supplements, and baby cereals across 12 therapeutic categories for export to approximately 30 countries in Asia, Africa, and Europe.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Food Manufacturing (311)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)

akta.pro secondary industries

Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium) (AFAKAJAD), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Pharmaceutical manufacturing
• Herbal remedies
• Generic medicines
• Nutritional supplements
• Baby cereals

Headquarters

HQ city

Cairo

HQ country

Egypt

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products including herbal remedies, preparations with natural ingredients, and related healthcare products across multiple therapeutic areas.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Mepaco Medifood (legally Arab Company for Pharmaceuticals and Medicinal Plants) is an Egyptian pharmaceutical manufacturer that researches, produces, and supplies a portfolio of over 100 pharmaceutical products, herbal remedies, nutritional supplements, and baby cereals. Products are organized across therapeutic categories including cardiovascular, antibiotics, CNS, respiratory, urology, metabolic/diet control, NSAIDs, immune stimulants, vitamins/minerals/antioxidants, and GIT products, and are distributed domestically and exported to approximately 30 countries.

Product overview

Mepaco Medifood (Arab Company for Pharmaceuticals and Medicinal Plants) is an Egyptian pharmaceutical manufacturer with a broad portfolio of over 100 pharmaceutical products and food supplements organized across 12 therapeutic categories. The company's core offerings include: cardiovascular medications (Losartan, Irbesartan, Valsartan, Co-Valsartan combinations, Feloblock, Coenzyme Q10, L-Carnitine products); antibiotics (Augmacillin, Mepaclind, Mepafloxin, Mepafuran); gastrointestinal products (Mepacolon, Mepasil, Mepaspasmin, Cyncholine, Ginger); NSAIDs and bone products (Inflacam, Mepacofen, Mepabrufen, Uric pure); CNS medications (Stablentin, Citalomep, Ginko products, Dormival, Mepahist); respiratory products (Broncho syrups, Guaflex, Spanomep, Vocaleive); immune stimulants (Immulant products, Immu-C); diabetic and diet control products (Mepaphage Metformin variants, Mepaco Slim, Diaglu, Mepasweet-S); vitamins and mineral supplements (Amino18, Calcium D3F, Vitamin E, Coenzyme Q10 Forte); urology products (Pepon, Nanofreq, Kellagon, L-Arginine); and baby cereals (Rice, Wheat & Milk variants). The company specializes in herbal remedies and preparations with natural ingredients, and exports to approximately 30 countries across Asia, Africa, and Europe.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiovascular Medicines

Quantifiable outcome

• Supply market with High-Quality Pharmaceutical Products at affordable prices, helping human healthcare improvement

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Amoun Pharmaceutical: Egypt-based pharmaceutical manufacturer producing generics and specialty products across multiple therapeutic categories. Comparable as a fellow Egyptian broad-portfolio manufacturer serving similar domestic and regional channels.
• EIPICO (Egyptian International Pharmaceutical Industries Co.): One of Egypt's largest pharmaceutical manufacturers with a broad portfolio across multiple therapeutic areas. Comparable as a domestic Egyptian pharma peer competing in similar generics and dosage-form categories.
• EVA Pharma: Egypt-based pharmaceutical manufacturer with a broad therapeutic portfolio and significant export presence across MENA and Africa. Directly comparable to Mepaco in product breadth, Egypt-based manufacturing, and regional generics/herbal focus.
• Pharco Pharmaceuticals: Major Egyptian pharmaceutical group with a wide therapeutic portfolio and substantial MENA/Africa export footprint. Closely aligned with Mepaco in domestic Egyptian manufacturing and broad therapeutic coverage.

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer producing generics across multiple therapeutic areas for MENA markets. Comparable in broad generics portfolio and regional focus, though with primary concentration in Gulf rather than African markets.
• Spimaco (Saudi Pharmaceutical Industries & Medical Appliances Corp.): Saudi Arabia-based pharmaceutical manufacturer with broad therapeutic categories and regional Gulf/MENA distribution. Comparable as a fellow Arabic-market pharma manufacturer, though focused on Gulf rather than African export markets.

Emerging players

• Cipla: Indian-headquartered global generics manufacturer with deep presence in African and emerging markets. Comparable as a major exporter of affordable generics into the same African and Asian end-markets that Mepaco serves, though at much larger scale.

Broad incumbents

• Hikma Pharmaceuticals: Jordan-headquartered, publicly listed multinational with a large generics portfolio and significant MENA presence. Comparable as a broader incumbent competing in the same regional generic-pharma market, though with substantially greater scale and capital access.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mepaco-medifood

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mepaco Medifood